News + Filings Transactions Holdings
|
MORGENTHALER VENTURE PARTNERS IX LP
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/12/2021 | Doximity, Inc. | | Other (disposition) | Class A Common Stock | 8.5M | $0.00 | $0 | | 11/10/2021 |
| 11/10/2021 | Doximity, Inc. | | Conversion | Class A Common Stock | 17.1M | $0.00 | $0 | | 11/10/2021 |
| 11/10/2021 | Doximity, Inc. | | Conversion | Class B Common Stock | 17.1M | $0.00 | $0 | | 11/10/2021 |
| 06/28/2021 | Doximity, Inc. | | Conversion | Series B Preferred Stock | 15.4M | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Doximity, Inc. | | Conversion | Series C Preferred Stock | 1.7M | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Doximity, Inc. | | Conversion | Class B Common Stock | 17.1M | $0.00 | $0 | | 06/28/2021 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Common Stock | 921.3k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Common Stock | 61.3k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Series A Convertible Preferred Stock | 214.3k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Series B Convertible Preferred Stock | 217.8k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Series C Convertible Preferred Stock | 359.8k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Series D Convertible Preferred Stock | 129.4k | $0.00 | $0 | | 11/16/2018 |
| 11/16/2018 | VAPOTHERM INC | VAPO | Conversion | Series D-1 Convertible Preferred Stock | 61.3k | $0.00 | $0 | | 11/16/2018 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Sale | Common Stock | 340 | $13.00 | $4.4k | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Exercise (in-the-money or at-the-money) | Common Stock | 63k | $0.07 | $4.4k | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 523.4k | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 486.9k | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Purchase | Common Stock | 263.5k | $13.00 | $3.4M | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Exercise (in-the-money or at-the-money) | Warrants to Purchase Common Stock | 63k | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series A Preferred Stock | 9.7M | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series B-1 Preferred Stock | 3.7M | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series B-2 Preferred Stock | 3.4M | $0.00 | $0 | | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 1.4M | $0.00 | $0 | | 10/31/2016 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Conversion | COMMON STOCK | 1.8M | $10.00 | $18.1M | | 10/07/2014 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Purchase | COMMON STOCK | 350k | $10.00 | $3.5M | | 10/07/2014 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Conversion | SERIES A PREFERRED STOCK | 11k | $0.00 | $0 | | 10/07/2014 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Conversion | SERIES B PREFERRED STOCK | 419.2k | $0.00 | $0 | | 10/07/2014 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Conversion | SERIES C PREFERRED STOCK | 747.5k | $0.00 | $0 | | 10/07/2014 |
| 10/07/2014 | Calithera Biosciences, Inc. | CALA | Conversion | SERIES D PREFERRED STOCK | 634.2k | $0.00 | $0 | | 10/07/2014 |
|